Dual degradation mechanisms ensure disposal of NHE6 mutant protein associated with neurological disease.

Abstract excerpt

Clinical features characterizing Angelman syndrome, previously shown to be caused by disruption of UBE3A, were recently also described in neurologically disabled patients with mutations in SLC9A6, which encodes the Na(+)/H(+) exchanger NHE6. In the present work we have focused on NHE6Delta255-256, the protein product of a specific 6-bp patient deletion in SLC9A6. To resolve the molecular mechanism causing the...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Angelman Syndrome
• Share to Chromosomes, Human, Pair 15